Philippe Rochigneux

1.1k total citations
39 papers, 649 citations indexed

About

Philippe Rochigneux is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Philippe Rochigneux has authored 39 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Philippe Rochigneux's work include Cancer Immunotherapy and Biomarkers (18 papers), Palliative Care and End-of-Life Issues (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Philippe Rochigneux is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Palliative Care and End-of-Life Issues (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Philippe Rochigneux collaborates with scholars based in France, United States and Sweden. Philippe Rochigneux's co-authors include Anne-Sophie Chrétien, Renaud Sabatier, Anthony Gonçalvès, François Bertucci, Lucas Morin, Patrice Viens, Régis Aubry, Yvan Beaussant, Christophe Tournigand and Daniel Olive and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Philippe Rochigneux

38 papers receiving 647 citations

Peers

Philippe Rochigneux
Martine George United States
Benjamin A. Derman United States
George Zarkavelis Greece
Gerardo A. Vitiello United States
Alice Zervoudakis United States
Haiqing Ma China
Michelle Rashford United States
Joshua P. Kesterson United States
Shiven B. Patel United States
Kate Wheeler United Kingdom
Martine George United States
Philippe Rochigneux
Citations per year, relative to Philippe Rochigneux Philippe Rochigneux (= 1×) peers Martine George

Countries citing papers authored by Philippe Rochigneux

Since Specialization
Citations

This map shows the geographic impact of Philippe Rochigneux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Rochigneux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Rochigneux more than expected).

Fields of papers citing papers by Philippe Rochigneux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Rochigneux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Rochigneux. The network helps show where Philippe Rochigneux may publish in the future.

Co-authorship network of co-authors of Philippe Rochigneux

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Rochigneux. A scholar is included among the top collaborators of Philippe Rochigneux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Rochigneux. Philippe Rochigneux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velez, Maria A., Andy Han, Daniel Li, et al.. (2025). Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy. JCO Oncology Practice. 22(2). 306–313. 1 indexed citations
2.
Fouchardière, Christelle de la, Robert Cohen, Olivier Dubreuil, et al.. (2024). 504O IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort. Annals of Oncology. 35. S429–S429. 6 indexed citations
3.
Gilabert, Marine, Philippe Rochigneux, Olivıer Turrini, et al.. (2024). Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review. Frontiers in Oncology. 13. 1326676–1326676. 1 indexed citations
4.
Fouchardière, Christelle de la, Robert Cohen, Olivier Dubreuil, et al.. (2024). 1448P IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts. Annals of Oncology. 35. S899–S900. 4 indexed citations
5.
6.
Amodru, Vincent, Jean‐Marie Boher, Christophe Zemmour, et al.. (2023). Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records. Journal for ImmunoTherapy of Cancer. 11(8). e006786–e006786. 4 indexed citations
7.
Rochigneux, Philippe, Aaron Lisberg, Alejandro J. Garcia, et al.. (2022). Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer. Clinical Cancer Research. 28(23). 5136–5148. 20 indexed citations
8.
Gorvel, Laurent, et al.. (2022). Apport de l’intelligence artificielle aux données multi-omiques dans les cancers du sein traités par chimiothérapie néo-adjuvante. médecine/sciences. 38(10). 772–775. 1 indexed citations
9.
Rochigneux, Philippe, et al.. (2022). Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy. Seminars in Immunopathology. 45(1). 29–41. 3 indexed citations
10.
Rochigneux, Philippe, A Autret, Jérôme Guiramand, et al.. (2022). Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study. Frontiers in Oncology. 12. 1012712–1012712. 2 indexed citations
11.
Rochigneux, Philippe, Anne-Sophie Chrétien, Laurent Gorvel, et al.. (2021). Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology. Biomedicines. 9(6). 632–632. 36 indexed citations
12.
Rochigneux, Philippe, Alejandro J. Garcia, Brice Chanez, et al.. (2020). Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review. Frontiers in Immunology. 11. 1036–1036. 11 indexed citations
13.
Rochigneux, Philippe, François Bertucci, Anne-Sophie Chrétien, et al.. (2019). PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review. Cancers. 11(7). 1033–1033. 171 indexed citations
14.
Rochigneux, Philippe, Aaron Lisberg, Anne-Sophie Chrétien, et al.. (2019). P1.04-33 Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001. Journal of Thoracic Oncology. 14(10). S452–S453. 2 indexed citations
15.
Beaussant, Yvan, Étienne Daguindau, Adrien Chauchet, et al.. (2018). Hospital end-of-life care in haematological malignancies. BMJ Supportive & Palliative Care. 8(3). 314–324. 41 indexed citations
16.
Rochigneux, Philippe, N. Schleinitz, Mikaël Ebbo, et al.. (2018). Acute myositis. Anti-Cancer Drugs. 29(5). 477–481. 13 indexed citations
17.
Rochigneux, Philippe, et al.. (2018). Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors. Frontiers in Immunology. 9. 797–797. 34 indexed citations
18.
Rochigneux, Philippe, Lénaïg Mescam-Mancini, Erwan Bories, et al.. (2017). Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature Review. Case Reports in Oncology. 10(1). 66–76. 6 indexed citations
19.
Rochigneux, Philippe, Jean‐Luc Raoul, & Lucas Morin. (2016). Use of chemotherapy near the end of life for solid cancers: What factors matter?. Annals of Oncology. 27. vi455–vi455. 1 indexed citations
20.
Rochigneux, Philippe, Jean‐Luc Raoul, Yvan Beaussant, et al.. (2016). Use of chemotherapy near the end of life: what factors matter?. Annals of Oncology. 28(4). 809–817. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martine George Breakdown of academic impact, for papers by Benjamin A. Derman Breakdown of academic impact, for papers by George Zarkavelis Breakdown of academic impact, for papers by Gerardo A. Vitiello Breakdown of academic impact, for papers by Alice Zervoudakis Breakdown of academic impact, for papers by Haiqing Ma Breakdown of academic impact, for papers by Michelle Rashford Breakdown of academic impact, for papers by Joshua P. Kesterson Breakdown of academic impact, for papers by Shiven B. Patel Breakdown of academic impact, for papers by Kate Wheeler
Rankless by CCL
2026